Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China

Emerging Microbes and Infections

Volumn 5, Issue 11, 2016, Pages

  Wang, Wenling ^a   Wang, Huijuan ^a   Deng, Yao ^a   Song, Tie ^b   Lan, Jiaming ^a   Wu, Guizhen ^a   Ke, Changwen ^b   Tan, Wenjie ^a  

^a BEIJING HOSPITAL   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

antibody; enzyme linked immunosorbent assay; MERS CoV; patient; recombinant structural antigens

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS ANTIBODY; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; CORONAVIRUS SPIKE GLYCOPROTEIN; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; BODY TEMPERATURE; CASE REPORT; CHINA; CONTROLLED STUDY; CORONAVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL HISTORY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS S PSEUDOVIRUS PARTICLE BASED NEUTRALIZATION TEST; PRIORITY JOURNAL; RECEPTOR BINDING; SEROCONVERSION; VENOUS BLOOD; VIRUS NEUTRALIZATION; BLOOD; CHEMISTRY; IMMUNOLOGY; SERODIAGNOSIS; VIROLOGY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHINA; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NEUTRALIZATION TESTS; NUCLEOPROTEINS; RECOMBINANT PROTEINS; SPIKE GLYCOPROTEIN, CORONAVIRUS;

EID: 84994494517     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2016.114     Document Type: Article

References (15)

1. World Health Organization (WHO). Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - Saudi Arabia, Disease Outbreak News, 23 March 2016. Geneva, Switzerland: WHO, 2016. Available from: http://www.who.int/csr/don/23-march-2016-mers-saudi-arabia/en/ (accessed 12 April 2016).
2. Da Guan W, Mok CK, Chen ZL et al. Characteristics of traveler with Middle East respiratory syndrome, China. 2015Emerg Infect Dis 2015; 21: 2278-2280.
3. Park SW, Perera RA, Choe PG et al. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill 2015; 20: 41.
4. Wernery U, El Rasoul IH, Wong EY et al. A phylogenetically distinct Middle East respiratory syndrome coronavirus detected in a dromedary calf from a closed dairy herd in Dubai with rising seroprevalence with age. Emerg Microbes Infect 2015; 4: e74.
5. Drosten C, Meyer B, Müller MA et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014; 371: 828-835.
6. Park WB, Perera RA, Choe PG et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis 2015; 21: 2186-2189.
7. Wu J, Yi L, Zou L et al. Imported case of MERS-CoV infection identified in China, May 2015: detection and lesson learned. Euro Surveill 2015; 20.
8. Lu G, Hu Y, Wang Q et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013; 500: 227-231.
9. Wang YQ, Hao CX, Deng Y et al. Prokaryotic expression, purification and identification of the Nprotein of Middle East respiratory syndrome coronavirus. Chin J Microbiol Immunol 2014; 34: 764-769.
10. Lan J, Yao Y, Deng Y et al. Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge. EBio Medicine 2015; 2: 1438-1446.
11. Zhao J, Wang W, Wang W et al. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS. Clin Vaccine Immunol 2007; 14: 839-846.
12. Woo PC, Lau SK, Wong BH et al. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol 2004; 11: 665-668.
13. Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 2003; 349: 508-509.
14. Corman VM, Albarrak AM, Omrani AS et al. Viral shedding and antibody response in 37 patients with MERS-coronavirus infection. Clin Infect Dis 2016; 62: 477-483.
15. Min CK, Cheon S, Ha NY et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016; 6: 25359.